Kidney Progenitor Cells in Disease
疾病中的肾脏祖细胞
基本信息
- 批准号:8268567
- 负责人:
- 金额:$ 53.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Renal Failure with Renal Papillary NecrosisAddressAdultAgingAttentionBlood VesselsCellsCellular biologyChronic Kidney FailureCollaborationsDiseaseEnd stage renal failureEndothelial CellsEpithelialFeasibility StudiesGeneticGoalsGrowthHealthInjuryInjury to KidneyKidneyMapsMonoclonal Antibody R24Natural regenerationNephronsOrgan failurePericytesPhaseRegenerative MedicineReninResearch PersonnelStem cellsTechniquesinterstitialkidney cellnephrogenesispodocytepreventprogenitorresponseresponse to injuryskillsstemstem cell biologysuccesstool
项目摘要
DESCRIPTION (provided by applicant): Understanding normal mechanisms of kidney regeneration in response to injuries is of vital importance to developing new therapies to tackle the increasing burden of chronic kidney disease and organ failure. Although the adult mammalian kidney lacks nephron progenitors that could regenerate entire nephrons, nevertheless it has remarkable capacity to regenerate. Recent studies have focused predominantly on tubule regeneration, yet have failed to identify an epithelial progenitor cell in adult kidney. However, there has been little attention to the vasculature. The overall goal of this
application is to identify and study adult kidney quiescent stem/progenitor cells. Accordingly, a team of four experts has come together bringing unique backgrounds and skills including stem cell biology. Renin cell biology, kidney development, glomerular and interstitial injuries, and Regenerative Medicine specifically identify and characterize latent progenitors lying within the kidney. In exciting new feasibility studies using unique genetic tools, these investigators have shown evidence of recent collaborations by identifying putative latent progenitor cells that are activated in response to kidney injuries and growth. These cells yield progeny that repopulate vascular mural cells of the glomerulus (podocytes) and interstitium (pericytes and endothelial cells). In the first year of this R24 application (Phase I, addressed here) the investigators plan
to establish irrefutably the presence and capacity of these latent progenitors using two distinct but complementary state-of-the-art fate mapping techniques in kidneys. Assuming the success of Phase I, the Investigators will then propose Phase II (years 2-5 of the R24 application) in which they will methodically dissect how these progenitors are activated, what lineal restrictions
exist in the progeny of these progenitors, study their capacity in aging, and attempt to harness these progenitors to promote kidney cell regeneration.
PUBLIC HEALTH RELEVANCE: Acute Kidney Injury, Chronic Kidney Disease and End Stage Kidney Disease are major health burdens. Understanding how the kidney regenerates in response to injuries is vital to generating new therapies that will prevent or limit the developmen of chronic kidney disease or end stage kidney disease. These initial studies will study progenitor cells in the adult kidney that have the capacity to generate new kidney cells, particularly of the blood vessels of the kidney. The investigators will determine how important these progenitors are in regeneration after kidney damage.
描述(由申请人提供):了解损伤后肾脏再生的正常机制对于开发新的治疗方法来解决慢性肾脏疾病和器官衰竭日益增加的负担至关重要。尽管成年哺乳动物肾脏缺乏能够再生整个肾元的肾元祖细胞,但它具有显著的再生能力。最近的研究主要集中在小管再生上,但未能在成人肾脏中鉴定上皮祖细胞。然而,很少有人关注血管系统。总的目标是
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy.
- DOI:10.1002/path.4801
- 发表时间:2016-12
- 期刊:
- 影响因子:0
- 作者:Ieronimakis N;Hays A;Prasad A;Janebodin K;Duffield JS;Reyes M
- 通讯作者:Reyes M
Resident mesenchymal cells and fibrosis.
- DOI:10.1016/j.bbadis.2012.11.015
- 发表时间:2013-07
- 期刊:
- 影响因子:6.2
- 作者:Hutchison, Nicol;Fligny, Cecile;Duffield, Jeremy S.
- 通讯作者:Duffield, Jeremy S.
The FOXD1 lineage of kidney perivascular cells and myofibroblasts: functions and responses to injury.
- DOI:10.1038/kisup.2014.6
- 发表时间:2014-11
- 期刊:
- 影响因子:5.5
- 作者:Gomez IG;Duffield JS
- 通讯作者:Duffield JS
Myofibroblasts in Fibrotic Kidneys.
- DOI:10.1007/s40139-013-0025-8
- 发表时间:2013-09-01
- 期刊:
- 影响因子:0
- 作者:Nakagawa N;Duffield JS
- 通讯作者:Duffield JS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH W GROSS其他文献
KENNETH W GROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH W GROSS', 18)}}的其他基金
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma
Epi)原发性和转移性胰岛细胞癌的基因组驱动因素
- 批准号:
8637941 - 财政年份:2013
- 资助金额:
$ 53.34万 - 项目类别:
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma
Epi)原发性和转移性胰岛细胞癌的基因组驱动因素
- 批准号:
8656515 - 财政年份:2013
- 资助金额:
$ 53.34万 - 项目类别:
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma
Epi)原发性和转移性胰岛细胞癌的基因组驱动因素
- 批准号:
8511195 - 财政年份:2013
- 资助金额:
$ 53.34万 - 项目类别:
A novel murine model for metastatic islet cell pancreas cancer
转移性胰岛细胞胰腺癌的新型小鼠模型
- 批准号:
8229338 - 财政年份:2012
- 资助金额:
$ 53.34万 - 项目类别:
A novel murine model for metastatic islet cell pancreas cancer
转移性胰岛细胞胰腺癌的新型小鼠模型
- 批准号:
8435352 - 财政年份:2012
- 资助金额:
$ 53.34万 - 项目类别:
Evaluation of Pericyte Molecular Markers in Clear Cell Kidney Cancer
透明细胞肾癌周细胞分子标志物的评价
- 批准号:
7086088 - 财政年份:2006
- 资助金额:
$ 53.34万 - 项目类别:
Evaluation of Pericyte Molecular Markers in Clear Cell Kidney Cancer
透明细胞肾癌周细胞分子标志物的评价
- 批准号:
7230150 - 财政年份:2006
- 资助金额:
$ 53.34万 - 项目类别:
TRANSGENIC MUTANT WITH DOPAMINERGIC SYSTEM DYSFUNCTION
多巴胺能系统功能障碍的转基因突变体
- 批准号:
3430356 - 财政年份:1993
- 资助金额:
$ 53.34万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 53.34万 - 项目类别:
Research Grant














{{item.name}}会员




